A short course of chemotherapy followed by chemoradiotherapy significantly improved progression-free survival and overall survival in women with locally advanced cervical cancer, according to a ...
Tevimbra plus chemotherapy improved overall survival in patients with advanced ESCC, with 68.3% achieving a response. Median time to response was 6.1 weeks, with most responses occurring within eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback